BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+5.47%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$294M
AUM Growth
+$294M
(-0.89%)
Cap. Flow
-$9.31M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
92.53%
Holding
16
New
3
Increased
2
Reduced
7
Closed
4
Top Buys
| 1 |
Medtronic
MDT
|
$35.4M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$23.1M |
| 3 |
Intuitive Surgical
ISRG
|
$19.3M |
| 4 |
Pennant Group
PNTG
|
$1.96M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$967K |
Top Sells
| 1 |
Globus Medical
GMED
|
$15.2M |
| 2 |
IDEAYA Biosciences
IDYA
|
$13.5M |
| 3 |
IQVIA
IQV
|
$11.2M |
| 4 |
Genworth Financial
GNW
|
$10.7M |
| 5 |
Perrigo
PRGO
|
$8.9M |
Sector Composition
| 1 | Healthcare | 80.58% |
| 2 | Financials | 19.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$11.9B
| $57.1M | 19.42% | 700,600 -103,265 | -13% | -$8.41M |
|
|
2
Medtronic
MDT
$119B
| $35.4M | 12.04% | +393,737 | New | +$35.4M |
|
|
3
Mirum Pharmaceuticals
MIRM
$3.71B
| $27.2M | 9.25% | 603,318 +21,475 | +4% | +$967K |
|
|
4
Globus Medical
GMED
$8.27B
| $26.4M | 8.99% | 360,764 -207,701 | -37% | -$15.2M |
|
5
Cigna
CI
$80.3B
| $23.3M | 7.93% | 70,859 -15,002 | -17% | -$4.94M |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $23.1M | 7.87% | +327,279 | New | +$23.1M |
|
7
Molina Healthcare
MOH
$9.8B
| $22.3M | 7.57% | 67,555 -14,287 | -17% | -$4.71M |
|
|
8
Perrigo
PRGO
$3.27B
| $19.8M | 6.73% | 704,824 -317,545 | -31% | -$8.9M |
|
|
9
Intuitive Surgical
ISRG
$170B
| $19.3M | 6.56% | +38,930 | New | +$19.3M |
|
|
10
Pennant Group
PNTG
$830M
| $18.1M | 6.16% | 719,137 +77,882 | +12% | +$1.96M |
|
11
Orthofix Medical
OFIX
$592M
| $15.5M | 5.26% | 948,202 -109,111 | -10% | -$1.78M |
|
12
Biohaven
BHVN
$1.63B
| $6.5M | 2.21% | 270,198 -91,222 | -25% | -$2.19M |
|
|
13
Genworth Financial
GNW
$3.52B
| – | – | -1,536,612 | Closed | -$10.7M |
|
|
14
IDEAYA Biosciences
IDYA
$2.15B
| – | – | -524,868 | Closed | -$13.5M |
|
|
15
IQVIA
IQV
$32.4B
| – | – | -57,141 | Closed | -$11.2M |
|
16
Viking Therapeutics
VKTX
$3.04B
| – | – | -209,853 | Closed | -$8.44M |
|